You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,910,225


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,910,225
Title: Locally administrable therapeutic composition for inflammatory disease
Abstract:This invention relates to a locally administrable therapeutic composition for inflammatory disease which is characterized by comprising benzoylphenylacetic acid of the formula ##STR1## (wherein R is a hydrogen or halogen atom), or a salt thereof, or the hydrate of said acid or salt, as active ingredient. An ophthalmic composition according to the invention can treat effectively inflammatory eye disease by topical application, is not an irritant to the eye, and has a superior effect to conventional drugs of the same or similar type. The aqueous composition prepared in accordance with this invention has excellent stability and can be used advantageously as a nasal or otic composition as well as an ophthalmic one in the treatment of inflammatory otic or nasal disease.
Inventor(s): Ogawa; Takahiro (Nishinomiya, JP), Kuribayashi; Yoshikazu (Kobe, JP), Ushio; Kazumichi (Nishinomiya, JP), Ohtori; Akira (Nara, JP)
Assignee: Senju Pharmaceutical Co., Ltd. (Osaka, JP) A. H. Robins Company, Incorporated (Richmond, VA)
Application Number:07/301,033
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of U.S. Patent 4,910,225: A Comprehensive Guide

Introduction

U.S. Patent 4,910,225, titled "Locally Administrable Therapeutic Agents," is a significant patent that has contributed to the development of therapeutic agents, particularly in the field of ophthalmology. This article will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background of the Patent

Patent Overview

U.S. Patent 4,910,225 was granted for the invention of locally administrable therapeutic agents, specifically focusing on ophthalmic applications. The patent describes methods and compositions for delivering therapeutic agents directly to the eye, which is crucial for treating various ocular conditions.

Scope of the Patent

Therapeutic Agents and Delivery Methods

The patent covers a wide range of therapeutic agents, including anti-inflammatory, antibacterial, and antiviral compounds. It details various delivery methods such as eye drops, ointments, and implants, designed to ensure the effective and localized administration of these agents to the eye[5].

Specific Compounds and Formulations

The patent specifies the use of certain compounds like bromfenac and its derivatives, which are known for their anti-inflammatory properties. These compounds are formulated in a way that enhances their stability and efficacy when administered locally to the eye[1].

Claims of the Patent

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broad scope of the invention, while dependent claims narrow down the scope by adding specific limitations. For example, one independent claim might cover the use of a particular therapeutic agent in an ophthalmic formulation, while a dependent claim could specify the concentration of the agent or the method of administration[3].

Claim Construction

Claim construction is critical in understanding the patent's scope. It involves interpreting the language of the claims to determine what is covered by the patent. In the case of U.S. Patent 4,910,225, claim construction would help in identifying which therapeutic agents and delivery methods are protected under the patent[5].

Patent Landscape

Related Patents and Applications

The patent landscape surrounding U.S. Patent 4,910,225 includes other patents and applications related to ophthalmic therapeutic agents. For instance, patents like the one described in the Canadian Patents Database (CA 2483275) also deal with the use of amfenac and nepafenac for treating vascular endothelial growth factor-mediated vascular disorders, indicating a broader interest in similar therapeutic areas[4].

Competitors and Market Impact

Understanding the patent landscape helps in identifying competitors and potential market impacts. Companies like Alcon, Inc., which have been involved in the development and commercialization of ophthalmic products, would be key players in this landscape. Analyzing their patent portfolios and claims can reveal gaps or opportunities in the market[4].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

To fully understand the protection offered by U.S. Patent 4,910,225, a Claim Coverage Matrix can be used. This tool categorizes patents by claims and scope concepts, helping to identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Scope Concepts and Claim Charts

Scope concepts are overarching categories that link claims on similar patents. Using tools like ClaimScape® software, interactive claim charts can be generated to review patent coverage with technical experts. These charts help in determining whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage is lacking[3].

Industry Impact and Future Directions

Current Applications and Research

The therapeutic agents and delivery methods described in U.S. Patent 4,910,225 have significant implications for the treatment of ocular diseases. Current research and applications focus on enhancing the efficacy and safety of these agents, as well as exploring new delivery methods such as nanotechnology and biodegradable implants.

Future Opportunities

The patent landscape suggests several future opportunities, including the development of new therapeutic agents and more advanced delivery systems. Companies can use patent analytics to identify areas of high value and potential future directions, guiding their research and development efforts.

Regulatory and Legal Considerations

Patent Expiration and Maintenance

Patents have a limited lifespan, and maintaining them requires periodic payments of maintenance fees. Understanding the expiration dates and maintenance requirements of patents like U.S. Patent 4,910,225 is crucial for managing intellectual property portfolios effectively[4].

Litigation and Enforcement

Patent litigation and enforcement are critical aspects of protecting intellectual property. Companies must be vigilant in monitoring potential infringements and taking legal action when necessary to protect their patented inventions.

Key Takeaways

  • Therapeutic Agents: U.S. Patent 4,910,225 covers a variety of therapeutic agents, including anti-inflammatory and antibacterial compounds.
  • Delivery Methods: The patent details various delivery methods such as eye drops, ointments, and implants.
  • Claim Construction: Accurate claim construction is essential for understanding the scope of the patent.
  • Patent Landscape: The patent landscape includes related patents and applications, competitors, and market impacts.
  • Future Directions: The development of new therapeutic agents and advanced delivery systems presents significant future opportunities.

FAQs

What is the main focus of U.S. Patent 4,910,225?

The main focus of U.S. Patent 4,910,225 is on locally administrable therapeutic agents, particularly for ophthalmic applications.

Which compounds are specifically mentioned in the patent?

The patent specifically mentions compounds like bromfenac and its derivatives, known for their anti-inflammatory properties.

How is claim construction important for this patent?

Claim construction is crucial for understanding the scope of the patent and determining what is covered by the claims.

What tool can be used to analyze the patent landscape?

A Claim Coverage Matrix and tools like ClaimScape® software can be used to analyze the patent landscape and identify gaps or opportunities.

What are the future directions in this field?

Future directions include the development of new therapeutic agents and more advanced delivery systems, such as nanotechnology and biodegradable implants.

How do companies maintain their patents?

Companies maintain their patents by paying periodic maintenance fees and monitoring potential infringements to protect their intellectual property.

Sources

  1. Google Patents: Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid.
  2. USPTO: Patent and patent application Claims data.
  3. SLWIP: Patent Analytics.
  4. Canadian Patents Database: Patent 2483275 Summary.
  5. Patent Docs: April 19, 2010.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,910,225

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,910,225

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan63-16683Jan 27, 1988

International Family Members for US Patent 4,910,225

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 80043 ⤷  Subscribe
Australia 2878689 ⤷  Subscribe
Australia 609932 ⤷  Subscribe
Canada 1325382 ⤷  Subscribe
Germany 68902649 ⤷  Subscribe
European Patent Office 0326915 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.